| Reagan-Udall Foundation

Tom Skelton, CEO of Surescripts, recently spoke with Dr. Amy Abernethy of the FDA, about the impact of COVID-19 and the evolving data needs of public health.

Read more about Surescripts Fireside Chat with Dr. Amy Abernethy, Principal Deputy Commissioner and Acting CIO, FDA

Read more about Oscillation and Lung Expansion Therapy in Patients With COVID-19

Read more about Patients Reactions Towards Their Diagnosis as Having COVID-19

Read more about Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)

Read more about Inflammatory Signal Inhibitors for COVID-19 (MATIS)

Read more about SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)

Read more about An Evaluation of a Synbiotic Formula for Patients With COVID-19 Infection

Read more about Send-In Sample Collection for Comprehensive Analyses of Innate and Adaptive Immune Responses During Acute COVID-19 and Convalescence

Read more about The Salivary Raman COVID-19 Fingerprint

Read more about The Provider Insurance Revenue Study in Healthcare Providers in the United States of America